The goal of the Clinical Core is to provide clinical resources to facilitate high quality clinical, neuropsychological, epidemiological and neuropathological research in Alzheimer's disease. There are three major operational components in the Clinical Core: 1) A uniform structured baseline clinical evaluation classifies subjects as to the presence or absence of Alzheimer's disease, collects initial psychometric, behavioral and physical function data for comparison with subsequent evaluations to permit measurement of change in these variables, and provides investigators with a uniform and comprehensive description of these variables to ensure a uniform common data set across a wide range of ongoing and future externally funded studies. 2) The branched annual follow-up evaluation was designed to achieve two general purposes. First, to provide a source of well characterized cases and controls with clinical status documented proximate to death to facilitate neuropathological studies. Second, to provide a pool of subjects for studies. 3) To efficiently distribute subjects into clinical, neuropsychological, epidemiological and neuropathological studies, consecutive subjects evaluated by the Core, determined to be eligible for one or more of a variety of externally funded studies will be recruited in a manner which minimizes the burden of studies on patients, their families and staff. To meet these goals, the Clinical Core will build on its successes during the first project period. From March 2, 1992 though August 15, 1995, 1837 persons underwent highly structured uniform clinical evaluations by the Clinical Core. Of these persons, 896 (48.8%) were distributed into in one or more of 20 externally funded studies, including studies requiring large numbers of persons with varying diagnoses across a wide range dementia severity to studies with highly restrictive entry requirements. Minority participation was also high; minorities comprised 18.1% of Clinical Core subjects and 19.2% of study participants.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-08
Application #
6267534
Study Section
Project Start
1998-07-01
Project End
1999-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Yu, Lei; Petyuk, Vladislav A; Gaiteri, Chris et al. (2018) Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol 84:78-88
Jansen, Willemijn J; Wilson, Robert S; Visser, Pieter Jelle et al. (2018) Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 61:138-145
Benedet, Andréa L; Yu, Lei; Labbe, Aurélie et al. (2018) CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. Neurol Genet 4:e216
Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93
Arvanitakis, Zoe; Leurgans, Sue E; Fleischman, Debra A et al. (2018) Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 83:718-729
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Wilson, Robert S; Capuano, Ana W; Yu, Lei et al. (2018) Neurodegenerative disease and cognitive retest learning. Neurobiol Aging 66:122-130
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 786 publications